Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

Publisher： Karger

E-ISSN： 1421-9867|82|1|47-53

ISSN： 0012-2823

Source： Digestion, Vol.82, Iss.1, 2010-03, pp. : 47-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Helicobacter pylori Therapy: First-Line Options and Rescue Regimen

By  

Digestive Diseases, Vol. 19, Iss. 2, 2001-08 ,pp. : 134-143

Karger

Access to resources Recommend Favorite

How to Proceed in Helicobacter pylori-Positive Chronic Gastritis Refractory to First- and Second-Line Eradication Therapy

By  

Digestive Diseases, Vol. 25, Iss. 3, 2007-09 ,pp. : 203-205

Karger

Access to resources Recommend Favorite

Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey

By  

Digestion, Vol. 92, Iss. 2, 2015-07 ,pp. : 55-59

Karger

Access to resources Recommend Favorite